← Back to Search

CAPABLE Transitions for Dementia

Waitlist Available
Led By Adam Simning, MD, PhD
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Screening 3 weeks
Treatment Varies
Follow Up month 3 to month 6 (3 months)
Awards & highlights

Study Summary

This trial is testing a new intervention to help with the transition of care for elderly patients discharged from a hospital or post-acute care facility. The intervention consists of in-home visits from an occupational therapist, nurse, and handyman over 3-4 months. The goal is to improve functioning and safety at home. A total of 60 older adults with and without dementia will be recruited for the study.

Eligible Conditions
  • Dementia
  • Transition Care


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 3 to month 6 (3 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 3 to month 6 (3 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Data Completeness on Clinical Outcomes
Percentage of Enrolled Participants That Are Retained
Percentage of Participants Screened as Eligible
+3 more
Secondary outcome measures
Health Services Use, Mean
Health Services Use, Percentage
Home Time in Days (From the 3 to 6 Month Period)
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CAPABLE TransitionsExperimental Treatment2 Interventions
Older adults admitted to University of Rochester Medicine Home Care with and without dementia will receive care as usual as well as CAPABLE-trained occupational therapy, registered nurse, and handyman services delivered over 3-4 months.
Group II: Care As UsualActive Control1 Intervention
Older adults admitted to University of Rochester Medicine Home Care (a Medicare-certified home health agency) with and without dementia will receive care as usual.
First Studied
Drug Approval Stage
How many patients have taken this drug
CAPABLE Transitions
Home Health Agency Care

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,668 Previous Clinical Trials
28,005,033 Total Patients Enrolled
265 Trials studying Dementia
23,623,380 Patients Enrolled for Dementia
University of RochesterLead Sponsor
836 Previous Clinical Trials
518,137 Total Patients Enrolled
5 Trials studying Dementia
1,207 Patients Enrolled for Dementia
Adam Simning, MD, PhD5.01 ReviewsPrincipal Investigator - University of Rochester
University of Rochester
5Patient Review
They were prompt, courteous, and seemed to genuinely care. I felt like I could trust them.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available spots left for prospective participants in this investigation?

"Affirmative. According to the information online at clinicaltrials.gov, this trial is actively looking for patients since it was first published on March 18th 2021 and edited again recently on September 1st 2022. Currently, 60 people are needed for the study in one site only."

Answered by AI

How extensive is the participation in this research endeavor?

"Indeed, the available information on clinicaltrials.gov indicates that this experiment is currently registering participants. This research was originally published on March 18th 2021 and has recently been modified as of September 1st 2022; at present, 60 individuals are necessary to be recruited from one center."

Answered by AI
~8 spots leftby Apr 2025